http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107088198-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e7f591b5057de036acdb552cee309c3b |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-585 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-585 |
| filingDate | 2016-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107088198-A |
| titleOfInvention | Applications of the Aphanalide L in treatment melanoma medicine is prepared |
| abstract | The invention discloses applications of the Aphanalide L in treatment melanoma medicine is prepared, belong to drug field.Research finds that Aphanalide L can significantly inhibit melanoma cells A375 growths, and cell number declines with Aphanalide L concentration in dependence, can further research and develop into the medicine for preparing treatment melanoma. |
| priorityDate | 2016-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.